Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Dyzantil 300mg prolonged-release tablets {equilateral_black_triangle}

Active Ingredient:
sodium valproate , valproic acid
Company:  
Aspire Pharma Ltd See contact details
ATC code: 
N03AG01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Valproate - Annual Risk Acknowledgement Form for females UK May 2025

Valproate - Annual Risk Acknowledgement Form for females May 2025 UK -aRMM

{pdf_link}

Valproate - Poster-Dispensary-Pregnancy Prevention Programme UK May 2025

Valproate - Poster-Dispensary-Pregnancy Prevention Programme UK 2023 - aRMM

{pdf_link}

Valproate - Risk Acknowledgement Form for males UK May 2025

Valproate - Risk Acknowledgement form for males UK May 2025 - aRMM

{pdf_link}

Valproate Female Patient Guide UK May 2025

Valproate Female Patient Guide UK May. 2025 - (aRMM)

{pdf_link}

Valproate Male Patient Guide UK May 2025

Valproate Male Patient Guide UK May. 2025 - aRMM.

{pdf_link}

Valproate- “White Box” Warning Labels

FOR DISPENSARY USE ONLY Warning Labels with Valproate Pregnancy Pictogram for Pharmacy to use with white box dispensing of these products.
{pdf_link}

Valproate- Healthcare professionals (HCPs) Guide Pregnancy prevention programme May 2025 UK

{healthcare_pro_orange} For Healthcare Professionals

Valproate - Healthcare professionals (HCPs) Guide UK May. 2025 (aRMM)

{pdf_link}

Valproate- Patient Card-Contraception and Pregnancy Prevention

Educational material for girls and women of childbearing potential about the Pregnancy Prevention Programme.
{pdf_link}

Valproate- Patient Guide- Pregnancy prevention programme

Educational material for girls and women of childbearing potential about the Pregnancy Prevention Programme.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Aspire Pharma Ltd
Company image
Address
4 Rotherbrook Court, Bedford Road, Petersfield, Hampshire, GU32 3QG, UK
Telephone
+44 (0)1730 231148
Medical Information Direct Line
+44 (0)1730 231148
Customer Care direct line
+44 (0)1730 231148
WWW
http://www.aspirepharma.co.uk